The decision followed a review of a pilot programme deployed since 2019 in Ghana, Kenya and Malawi in which more than two million doses wer...

One cannot have long-lasting immunity from malaria.

The agreement includes transfer of manufacturing of the protein part of the vaccine, RTS,S/AS01, while GSK will continue to supply Bharat B...

Tata Trusts chairman Ratan Tata, managing trustee R Venkataramanan and head of innovation Manoj Kumar will bet the trustees of the new Inst...

The Plasmodium falciparum parasite is responsible for most malaria infections and almost all deaths caused by the disease worldwide.

A new malaria vaccine candidate has been found to generate robust immune response while significantly delaying parasitemia in 59 per cent o...

Malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itself against the deadly disease, scientists...

The world's first malaria vaccine will be available in the market by next year. Pharma company GSK has submitted a regulatory application t...

The study says that a cocktail of AMA1 proteins from only a few different strains can overcome major limitations of an earlier designed ver...

The team are working to design molecules that target NMT more potently, and hope to start clinical trials of potential treatments.

Cadila Pharma and Novavax to develop new malaria vaccine using VLP technology. ICGEB also to partner them in the project.

Researchers at the Walter and Eliza Hall Institute of Medical Research, Australia, have found the evasion tactics of the malaria causing pa...